Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Value of EGFR Copy Number Gain Determined by Amplicon-Based Targeted Next Generation Sequencing in Patients with EGFR-Mutated NSCLC.
Wei J, Meng P, Terpstra MM, van Rijk A, Tamminga M, Scherpen F, Ter Elst A, Alimohamed MZ, Johansson LF, Stigt J, Gijtenbeek RPG, van Putten J, Hiltermann TJN, Groen HJM, Kok K, van der Wekken AJ, van den Berg A. Wei J, et al. Among authors: van der wekken aj, van putten j, van rijk a, van den berg a. Target Oncol. 2021 Mar;16(2):215-226. doi: 10.1007/s11523-021-00798-2. Epub 2021 Feb 19. Target Oncol. 2021. PMID: 33606136 Free PMC article.
Randomized, placebo-controlled phase III study of docetaxel plus carboplatin with celecoxib and cyclooxygenase-2 expression as a biomarker for patients with advanced non-small-cell lung cancer: the NVALT-4 study.
Groen HJ, Sietsma H, Vincent A, Hochstenbag MM, van Putten JW, van den Berg A, Dalesio O, Biesma B, Smit HJ, Termeer A, Hiltermann TJ, van den Borne BE, Schramel FM. Groen HJ, et al. Among authors: van den borne be, van putten jw, van den berg a. J Clin Oncol. 2011 Nov 10;29(32):4320-6. doi: 10.1200/JCO.2011.35.5214. Epub 2011 Oct 11. J Clin Oncol. 2011. PMID: 21990410 Clinical Trial.
Common and rare EGFR and KRAS mutations in a Dutch non-small-cell lung cancer population and their clinical outcome.
Kerner GS, Schuuring E, Sietsma J, Hiltermann TJ, Pieterman RM, de Leede GP, van Putten JW, Liesker J, Renkema TE, van Hengel P, Platteel I, Timens W, Groen HJ; CTMM Air Force Consortium. Kerner GS, et al. Among authors: van putten jw, van hengel p. PLoS One. 2013 Jul 29;8(7):e70346. doi: 10.1371/journal.pone.0070346. Print 2013. PLoS One. 2013. PMID: 23922984 Free PMC article.
Quality of life, geriatric assessment and survival in elderly patients with non-small-cell lung cancer treated with carboplatin-gemcitabine or carboplatin-paclitaxel: NVALT-3 a phase III study.
Biesma B, Wymenga ANM, Vincent A, Dalesio O, Smit HJM, Stigt JA, Smit EF, van Felius CL, van Putten JWG, Slaets JPJ, Groen HJM; Dutch Chest Physician Study Group. Biesma B, et al. Among authors: van putten jwg, van felius cl. Ann Oncol. 2011 Jul;22(7):1520-1527. doi: 10.1093/annonc/mdq637. Epub 2011 Jan 20. Ann Oncol. 2011. PMID: 21252061 Free article. Clinical Trial.
Systematic evaluation of the efficacy-effectiveness gap of systemic treatments in extensive disease small cell lung cancer.
Cramer-van der Welle CM, Schramel FMNH, Peters BJM, van Putten JWG, Klungel OH, Groen HJM, van de Garde EMW; Santeon SCLC Study Group. Cramer-van der Welle CM, et al. Among authors: van putten jwg, van de garde emw. Pharmacoepidemiol Drug Saf. 2021 Apr;30(4):445-450. doi: 10.1002/pds.5179. Epub 2020 Dec 18. Pharmacoepidemiol Drug Saf. 2021. PMID: 33295644
Concurrent gemcitabine and 3D radiotherapy in patients with stage III unresectable non-small cell lung cancer.
Kerner GS, van Dullemen LF, Wiegman EM, Widder J, Blokzijl E, Driever EM, van Putten JW, Liesker JJ, Renkema TE, Pieterman RM, Mertens MJ, Hiltermann TJ, Groen HJ. Kerner GS, et al. Among authors: van dullemen lf, van putten jw. Radiat Oncol. 2014 Aug 29;9:190. doi: 10.1186/1748-717X-9-190. Radiat Oncol. 2014. PMID: 25174943 Free PMC article. Clinical Trial.
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinoma.
Steendam CMJ, Peric R, van Walree NC, Youssef M, Schramel FMNH, Brocken P, van Putten JWG, van der Noort V, Veerman GDM, Koolen SLW, Groen HJM, Dingemans AC, Mathijssen RHJ, Smit EF, Aerts JGJV; NVALT Study Group. Steendam CMJ, et al. Among authors: van putten jwg, van walree nc, van der noort v. Lung Cancer. 2021 Oct;160:44-49. doi: 10.1016/j.lungcan.2021.08.002. Epub 2021 Aug 4. Lung Cancer. 2021. PMID: 34403911 Free article. Clinical Trial.
240 results